# ZILBRYSQ
> **NDA216834** · New Drug Application · Sponsor: UCB INC · Approved 2023-10-17
## Drug
- **FDA Application Number:** NDA216834
- **Application type:** New Drug Application
- **Brand name:** ZILBRYSQ
- **Generic name:** ZILUCOPLAN
- **Active ingredients:** ZILUCOPLAN SODIUM
- **Dosage form:** SOLUTION
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** UCB INC
- **Manufacturer:** UCB, Inc.
- **First approval:** 2023-10-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216834)
---
*AI Analytics · CC0 1.0*